Atlas Biomed Revenue and Competitors
Estimated Revenue & Valuation
- Atlas Biomed's estimated annual revenue is currently $5.1M per year.
- Atlas Biomed's estimated revenue per employee is $269,211
Employee Data
- Atlas Biomed has 19 Employees.
- Atlas Biomed grew their employee count by -30% last year.
Atlas Biomed's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Customer Service Operations Manager | Reveal Email/Phone |
Atlas Biomed Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.6M | 95 | 8% | $277M | N/A |
#2 | $258.5M | 710 | -19% | $1.1B | $2.4B |
What Is Atlas Biomed?
Atlas Biomed is a personalized health company applying the latest genetic technologies to inspire consumers into a positive lifestyle change, and lead them into a healthier future.
keywords:N/A
N/A
Total Funding
19
Number of Employees
$5.1M
Revenue (est)
-30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Atlas Biomed News
2022-04-17 - The human microbiome market is projected to reach USD 1,370 million by 2029
from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029
... DayTwo (US), BIOHM (US), Atlas Biomed (UK), Bione (India), Luxia Scientific (France), Sun Genomics (US), and Metabiomics (US).
2022-04-06 - Direct to Consumer Microbiome Analyzing Market ...
Atlas Biomed Group Limited. Viome, Inc. 23andMe, Inc uBiome. Carbiotix AB BIOMES NGS GmbH. Quantbiome, Inc. TFTAK. The growth in number...
2022-03-30 - Human Microbiome-based Gut Health Test and Nutrition ...
... Hyperbiotics, Everidis, Floraster, Enfamil, Culturelle, Biogaia, Viome, Atlas Biomed, Nouri, Bayer Consumer Health, Clasado Biosciences,...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 19 | -54% | $18.6M |
#2 | $2.5M | 19 | -34% | N/A |
#3 | $2.7M | 19 | -41% | N/A |
#4 | $9.4M | 19 | -72% | N/A |
#5 | $2.7M | 19 | -27% | N/A |